NDC 35781-0500-3 - WPR Plus
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 35781-0500
- Requested NDC
- 35781-0500-3
- Package NDCs from labels
- 35781-0500-3, 35781-0500-1, 35781-0500-9
- Manufacturer
- International Brand Management, LLC | Gensco Laboratories, LLC
- Effective date
- 2018-07-17
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| WPR Plus - International Brand Management, LLC | Gensco Laboratories, LLC | International Brand Management, LLC | Gensco Laboratories, LLC | 2018-07-17 | HUMAN PRESCRIPTION DRUG LABEL |
| WPR Plus - International Brand Management, LLC | International Brand Management, LLC | 2018-07-17 | HUMAN OTC DRUG LABEL |
| Lidocaine Hydrochloride - Gensco Laboratories, LLC | Gensco Laboratories, LLC | 2015-10-01 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 35781-0500-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d18c-f424-e053-dadaa90a57ce | LDO Plus (Lidocaine HCl USP) 4% |
| 35781-0500-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d18c-f424-e053-dadaa90a57ce | LDO Plus (Lidocaine HCl USP) 4% |
| 35781-0500-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d18c-f424-e053-dadaa90a57ce | LDO Plus (Lidocaine HCl USP) 4% |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 35781-0500-3 | WPR Plus | 30 g in 1 TUBE | 30 g | 40 mg in 1g | 2 | |
| 35781-0500-1 | Lidocaine Hydrochloride | 15 g in 1 TUBE | GEL | 15 | 1 | |
| 35781-0500-1 | Lidocaine Hydrochloride | 1 in 1 CARTON | GEL | 1 | 1 | |
| 35781-0500-3 | WPR Plus | 30 g in 1 TUBE | 30 g | 40 mg in 1g | 1 | |
| 35781-0500-3 | Lidocaine Hydrochloride | 1 in 1 CARTON | GEL | 1 | 1 | |
| 35781-0500-3 | Lidocaine Hydrochloride | 30 g in 1 TUBE | GEL | 30 | 1 | |
| 35781-0500-9 | Lidocaine Hydrochloride | 1 in 1 CARTON | GEL | 1 | 1 | |
| 35781-0500-9 | Lidocaine Hydrochloride | 90 g in 1 TUBE | GEL | 90 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 35781-0500 | WPR PLUS () KIT [INTERNATIONAL BRAND MANAGEMENT, LLC] | 2 | Unmatched | 20180801_9d830535-2202-482d-9d1a-bccd7bbba855.zip |
| 35781-0500 | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | 6 package rows | 20151028_88dbd438-02c0-481a-bdb7-8b3f3c41fd46.zip |
| 35781-0500 | WPR PLUS () KIT [INTERNATIONAL BRAND MANAGEMENT, LLC] | 1 | Unmatched | 20180717_793d6fad-31a7-4b28-8395-73825bc18508.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 35781-0500-3 | ML - Milliliter | 35781-0500 | e34c830a-ebae-4476-af71-631a4ac662bc | 1 | 2015-11-12 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LIDOCAINE | ACTIVE INGREDIENT | 98PI200987 | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| FILIPENDULA ULMARIA FLOWER | INACTIVE INGREDIENT | 06L18L32G6 | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| POLYETHYLENE GLYCOL 3350 | INACTIVE INGREDIENT | G2M7P15E5P | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| QUERCUS ALBA WOOD | INACTIVE INGREDIENT | XR6BC2ZUAM | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 | |
| ZINC ACETATE | INACTIVE INGREDIENT | FM5526K07A | LIDOCAINE HYDROCHLORIDE (LIDOCAINE) GEL [GENSCO LABORATORIES, LLC] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Germa Manteca Ubre Plus (YELLOW) | METHYL SALICYLATE 10% | Germa Products, LLC | bf8fe43d-8106-658b-e053-2995a90ae44e | 2026-10-09 | Warnings | LAV5U5022Y |
| Germa Manteca Ubre Plus (RED) | METHYL SALICYLATE 10% | Germa Products, LLC | bf9060df-6886-6381-e053-2995a90aa0df | 2026-10-09 | Warnings | LAV5U5022Y |
| Germa Linimento Ubre Plus (Roll-On) | METHYL SALICYLATE 10% | Germa Products, LLC | bfddff61-f6b4-ba9f-e053-2995a90ac9c0 | 2026-10-09 | Warnings | LAV5U5022Y |
| Germa Vapozol Chest-Rub | MENTHOL | Germa Products, LLC | bfe0affe-9e6f-6f57-e053-2a95a90a49e5 | 2026-10-09 | Warnings | L7T10EIP3A |
| Germa Gel del Artico | MENTHOL 1% | Germa Products, LLC | bff1d37f-e8b7-7b72-e053-2995a90a8254 | 2026-10-09 | Warnings | L7T10EIP3A |
| Germa Ubre Mastitis | METHYL SALICYLATE 2% | Germa Products, LLC | bfc83a7d-49ed-d1e0-e053-2a95a90acf36 | 2026-10-09 | Warnings | LAV5U5022Y |
| LIDOCAINE | LIDOCAINE | PHARMACURE LLC | 53384c51-6da1-4fa4-8782-2606ca3d1c6f | 2026-10-09 | Warnings | 98PI200987 |
| Methyl Salicylate | METHYL SALICYLATE | PHARMACURE LLC | 8803ae01-ea48-46c2-ab64-bb273de605ac | 2026-10-09 | Warnings | LAV5U5022Y |
| Medicated Chest Rub | CAMPHOR, MENTHOL, EUCALYPTUS OIL | New Pride Corp | 5db7d54a-0b68-8f7b-e063-6394a90a4c33 | 2026-10-09 | Warnings | L7T10EIP3A |
| good sense clearlax | POLYETHYLENE GLYCOL 3350 | L. Perrigo Company | 9858edef-cdb2-4ac4-8e4b-ba0720a24e41 | 2026-10-09 | Warnings | G2M7P15E5P |
| Equate Anti Itch | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | Wal-Mart Stores Inc | 97a12fef-d5eb-453c-8c0d-6642f873ec82 | 2026-10-08 | Warnings | FM5526K07A |
| GoLYTELY | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Braintree Laboratories, Inc. | 57d22b0b-1ae0-4203-babc-f3bac17bd1c9 | 2026-10-08 | Warnings, Adverse reactions | G2M7P15E5P |
| PEG-3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 448db7a5-1fea-4bf3-b1f5-e9d027a36603 | 2026-10-08 | Warnings, Adverse reactions | G2M7P15E5P |
| PEG-3350, sodium chloride, sodium bicarbonate and potassium chloride | POLYETHYLENE GLYCOL 3350, SODIUM CHLORIDE, SODIUM BICARBONATE, POTASSIUM CHLORIDE | Affordable Pharmaceuticals, LLC | 89ca6d56-527a-4be2-baea-531156f0a7be | 2026-10-08 | Warnings, Adverse reactions | G2M7P15E5P |
| SUPREP Bowel Prep | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Braintree Laboratories, Inc. | 2f5f06de-ee98-44c0-be7e-9a998d1e5c16 | 2026-10-08 | Warnings, Adverse reactions | DE08037SAB |
| SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE | SODIUM SULFATE, POTASSIUM SULFATE, MAGNESIUM SULFATE | Affordable Pharmaceuticals, LLC | f86bdcc8-e643-4160-89ae-01c89bee842d | 2026-10-08 | Warnings, Adverse reactions | DE08037SAB |
| Epsom Salt | MAGNESIUM SULFATE | Family Dollar (FAMILY WELLNESS) | 7de802aa-6c31-451c-995c-8549b2545c69 | 2026-10-07 | Warnings | DE08037SAB |
| Hot/Cold Menthol 16% Roll-On | HOT/COLD MENTHOL 16% ROLL-ON | Meijer, Inc. | 5d432c0b-dc4d-ad6b-e063-6294a90a7502 | 2026-10-07 | Warnings | L7T10EIP3A |
| JELVOXA DMSO | MENTHOL CAMPHOR CAPSAICIN | Vange Life Technology Co., Limited | 5d43aff1-a87b-43a3-e063-6294a90af642 | 2026-10-07 | Warnings | L7T10EIP3A |
| MENTOL ICE gel | MENTHOL, CAMPHOR | BOE Dominicana SRL | 5d45c982-eb82-b88c-e063-6394a90ae513 | 2026-10-07 | Warnings | L7T10EIP3A |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.